| Characteristics of patients experiencing extrapyramidal symptoms or other movement disorders related to dopamine receptor blocking agent therapy S Musco, L Ruekert, J Myers, D Anderson, M Welling, EA Cunningham Journal of clinical psychopharmacology 39 (4), 336-343, 2019 | 40 | 2019 |
| Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatment S Musco, V McAllister, I Caudle Therapeutic Advances in Psychopharmacology 10, 2045125320937575, 2020 | 19 | 2020 |
| Attitudes and perceptions about the use of long-acting injectable antipsychotics among behavioral health practitioners S Schwartz, C Carilli, T Mian, L Ruekert, A Kumar Mental Health Clinician 12 (4), 232-240, 2022 | 12 | 2022 |
| Mental and physical health among students at a private university that held in-person classes during the COVID-19 pandemic SE Schwartz, SG Ross, JA Bryant, JD Duncan Journal of American College Health 72 (2), 587-597, 2024 | 6 | 2024 |
| Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: a systematic review and meta-analysis of cohort studies S Lee, S Schwartz Psychiatry research 306, 114277, 2021 | 6 | 2021 |
| Impact of a multidisciplinary educational training program (OverdosED) on knowledge and perceptions of depressant substance use on a college campus S Musco, B Hargett, T Shollenberger, J Kicklighter, C Carilli Journal of American college health 69 (8), 820-826, 2021 | 6 | 2021 |
| Expanding naloxone education in the doctor of pharmacy curriculum S Musco, J Kicklighter, A Arnett Currents in Pharmacy Teaching and Learning 14 (3), 310-317, 2022 | 5 | 2022 |
| Assessing Psychiatric Comorbidity and pharmacologic treatment patterns among patients with neurofibromatosis type 1 AC Houpt, SE Schwartz, RA Coover Cureus 13 (12), 2021 | 5 | 2021 |
| Shifting from SOAP notes to consult notes for clinical documentation by pharmacy students CL Bradley, K Wieder, SE Schwartz American Journal of Pharmaceutical Education 86 (7), 8781, 2022 | 4 | 2022 |
| Communicating definitive uncertainty: Teaching pharmacy students to say “I don't know” CL Bradley, SE Schwartz, JB Cooper Currents in Pharmacy Teaching and Learning, 2021 | 4 | 2021 |
| Development and evaluation of a pharmacist-driven screening tool to identify patients presenting to the emergency department who are eligible for outpatient treatment of deep … SE Musco, SM Smallwood, J Gossard Journal of Pharmacy Practice 34 (3), 378-385, 2021 | 3 | 2021 |
| Dangers of rapid dosing: a case of dose-dependent drug-induced liver injury from duloxetine AS Kassam, EA Cunningham, SE Musco The Primary Care Companion for CNS Disorders 21 (2), 27206, 2019 | 3 | 2019 |
| Characteristics of inpatients prescribed dopamine receptor blocking agents S Schwartz, L Dinkla, J Pullen, R Bernard, A Kumar Psychopharmacology bulletin 51 (4), 51, 2021 | 2 | 2021 |
| Practical Approaches to Antipsychotic-Associated Corrected QT Interval Prolongation in Patients With Serious Mental Illness: A Review of Cases AL Cunha, SE Schwartz, JB Cooper Journal of Pharmacy Practice 36 (4), 817-829, 2023 | 1 | 2023 |
| Tricyclic Antidepressant Overdose Manikin Simulation in Student Pharmacists AM Ebied, J Jessee, S Schwartz Journal of Pharmacy Technology 38 (6), 343-348, 2022 | 1 | 2022 |
| Utilization of Head Imaging in Children and Adolescents With First-Episode Psychosis: A Retrospective Analysis V Doda, A Kumar, S Schwartz Cureus 16 (7), e65675, 2024 | | 2024 |
| Pharmacist Reported Protocols for QTc Monitoring of Psychiatric Medications K Harb, S Schwartz, J Cooper Cureus 16 (3), 2024 | | 2024 |
| Time‐to‐therapy discontinuation in patients newly diagnosed with schizophrenia initiated on long‐acting injectable versus oral dopamine receptor blocking agents S Schwartz, S Lee, EB Coble, C Troxler, S Toscano, A Kumar Early Intervention in Psychiatry 17 (9), 921-928, 2023 | | 2023 |
Jaclyn MyersPurdue University在 purdue.edu 的电子邮件经过验证
